AXOVANT SCIENCES LTD's ticker is AXGTXXXX and the CUSIP is G0750W104. A total of 2 filers reported holding AXOVANT SCIENCES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,503,000 | +1557.6% | 1,881,499 | +1138.0% | 0.00% | – |
Q4 2018 | $151,000 | -64.9% | 151,974 | -14.4% | 0.00% | – |
Q3 2018 | $430,000 | -41.3% | 177,506 | -45.3% | 0.00% | – |
Q2 2018 | $733,000 | +185.2% | 324,345 | +68.1% | 0.00% | – |
Q1 2018 | $257,000 | -92.8% | 192,933 | -71.4% | 0.00% | -100.0% |
Q4 2017 | $3,554,000 | -62.8% | 674,596 | -51.4% | 0.00% | -71.4% |
Q3 2017 | $9,559,000 | -2.8% | 1,389,410 | +227.6% | 0.01% | -12.5% |
Q2 2017 | $9,835,000 | -8.6% | 424,074 | -41.1% | 0.01% | -11.1% |
Q1 2017 | $10,758,000 | +188.8% | 720,115 | +140.1% | 0.01% | +200.0% |
Q4 2016 | $3,725,000 | +746.6% | 299,875 | +855.0% | 0.00% | – |
Q3 2016 | $440,000 | -94.0% | 31,400 | -94.5% | 0.00% | -100.0% |
Q2 2016 | $7,353,000 | +962.6% | 572,679 | +850.3% | 0.01% | +700.0% |
Q1 2016 | $692,000 | +412.6% | 60,266 | +704.6% | 0.00% | – |
Q4 2015 | $135,000 | -69.0% | 7,490 | -77.8% | 0.00% | – |
Q3 2015 | $435,000 | -37.0% | 33,680 | -0.6% | 0.00% | -100.0% |
Q2 2015 | $691,000 | – | 33,869 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,000,000 | $57,400,000 | 7.34% |
VHCP Management II, LLC | 429,590 | $4,932,000 | 3.24% |
VHCP Management, LLC | 184,110 | $2,114,000 | 1.84% |
Visium Asset Management, LP | 4,192,769 | $48,132,000 | 0.82% |
Perceptive Advisors | 485,000 | $5,568,000 | 0.49% |
Opus Point Partners Management, LLC | 26,416 | $303,000 | 0.23% |
Virtus ETF Advisers LLC | 12,579 | $144,000 | 0.20% |
BOURGEON CAPITAL MANAGEMENT LLC | 20,700 | $238,000 | 0.16% |
AMERICAN FINANCIAL GROUP INC | 172,395 | $1,980,000 | 0.15% |
NJ State Employees Deferred Compensation Plan | 51,000 | $640,000 | 0.14% |